293 related articles for article (PubMed ID: 23241138)
1. Urinary metabolomic signature of esophageal cancer and Barrett's esophagus.
Davis VW; Schiller DE; Eurich D; Sawyer MB
World J Surg Oncol; 2012 Dec; 10():271. PubMed ID: 23241138
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
[TBL] [Abstract][Full Text] [Related]
3. Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy.
Doran ST; Falk GL; Somorjai RL; Lean CL; Himmelreich U; Philips J; Russell P; Dolenko B; Nikulin AE; Mountford CE
Am J Surg; 2003 Mar; 185(3):232-8. PubMed ID: 12620562
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Evidence for a Field Effect in Histologically Normal and Metaplastic Tissues in Patients with Esophageal Adenocarcinoma.
Reed MAC; Singhal R; Ludwig C; Carrigan JB; Ward DG; Taniere P; Alderson D; Günther UL
Neoplasia; 2017 Mar; 19(3):165-174. PubMed ID: 28152423
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
Yang H; Gu J; Wang KK; Zhang W; Xing J; Chen Z; Ajani JA; Wu X
Clin Cancer Res; 2009 Sep; 15(18):5744-52. PubMed ID: 19737949
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
7. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
[TBL] [Abstract][Full Text] [Related]
10. Automated cytological detection of Barrett's neoplasia with infrared spectroscopy.
Old O; Lloyd G; Isabelle M; Almond LM; Kendall C; Baxter K; Shepherd N; Shore A; Stone N; Barr H
J Gastroenterol; 2018 Feb; 53(2):227-235. PubMed ID: 28501919
[TBL] [Abstract][Full Text] [Related]
11. Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening.
Konda VJ; Cherkezyan L; Subramanian H; Wroblewski K; Damania D; Becker V; Gonzalez MH; Koons A; Goldberg M; Ferguson MK; Waxman I; Roy HK; Backman V
Endoscopy; 2013 Dec; 45(12):983-8. PubMed ID: 24019132
[TBL] [Abstract][Full Text] [Related]
12. Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma.
Chiam K; Wang T; Watson DI; Mayne GC; Irvine TS; Bright T; Smith L; White IA; Bowen JM; Keefe D; Thompson SK; Jones ME; Hussey DJ
J Gastrointest Surg; 2015 Jul; 19(7):1208-15. PubMed ID: 25943911
[TBL] [Abstract][Full Text] [Related]
13. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus.
Shah AK; Hartel G; Brown I; Winterford C; Na R; Cao KL; Spicer BA; Dunstone MA; Phillips WA; Lord RV; Barbour AP; Watson DI; Joshi V; Whiteman DC; Hill MM
Mol Cell Proteomics; 2018 Dec; 17(12):2324-2334. PubMed ID: 30097534
[TBL] [Abstract][Full Text] [Related]
16. Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.
Sato F; Jin Z; Schulmann K; Wang J; Greenwald BD; Ito T; Kan T; Hamilton JP; Yang J; Paun B; David S; Olaru A; Cheng Y; Mori Y; Abraham JM; Yfantis HG; Wu TT; Fredericksen MB; Wang KK; Canto M; Romero Y; Feng Z; Meltzer SJ
PLoS One; 2008 Apr; 3(4):e1890. PubMed ID: 18382671
[TBL] [Abstract][Full Text] [Related]
17. Risk Prediction Models for Barrett's Esophagus Discriminate Well and Are Generalizable in an External Validation Study.
Ireland CJ; Thrift AP; Esterman A
Dig Dis Sci; 2020 Oct; 65(10):2992-2999. PubMed ID: 31897894
[TBL] [Abstract][Full Text] [Related]
18. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
19. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
[TBL] [Abstract][Full Text] [Related]
20. Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.
Bus P; Kestens C; Ten Kate FJ; Peters W; Drenth JP; Roodhart JM; Siersema PD; van Baal JW
J Gastroenterol; 2016 Jun; 51(6):560-70. PubMed ID: 26585599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
